|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
signaling
1 University of Milan
* To whom correspondence should be addressed. E-mail: michele.samaja{at}unimi.it.
| Abstract |
|---|
Exposure to hypoxia triggers in brain a variety of adverse effects that arise from metabolic stress and induce neuron apoptosis. Over-expression of the hypoxia inducible factor-1
(HIF-1
) is believed to be a major candidate in orchestrating the cell defense against stress. To test the impact of HIF-1
during chronic hypoxia in vivo on apoptosis, we examined the protective effect of modulating the NO/cyclic GMP pathway by sildenafil, a selective inhibitor of phosphodiesterase-5. Male ICR/CD-1 mice were divided into three groups (n=6/group): normoxic (21% O2), hypoxic (9.5% O2) and hypoxic with sildenafil (1.4 mg/kg ip daily injections). At the end of the 8-day treatment, mice were euthanized and cerebral cortex biopsies harvested for analyses. We found that sildenafil (1) did not alter the hypoxia-induced weight loss and hemoglobin increase, but augmented plasma nitrates+nitrites and the tissue content of cyclic GMP and phosphorylated NOS3; (2) reversed the hypoxia-induced neuron apoptosis (TdT-positivity and double-staining immunofluorescence, P=0.009), presumably through increased bcl-2/Bax (P=0.0005); and (3) did not affect HIF-1
, but blunted the hypoxia-induced increase in phosphorylated-ERK1/2 (P=0.0002) and p38 (P=0.004). We conclude that up-regulating the NO/cyclic GMP pathway by phosphodiesterase-5 inhibition during hypoxia reduces neuron apoptosis irrespectively of HIF-1
, through an interaction involving ERK1/2 and p38.
Key Words:
Chronic hypoxia, HIF-1
, NO, hypoxia signaling, bcl-2
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |